Study of IBB, XBI and LABU
- 08/08/2022
Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics – WSJ Pfizer’s purchase, together with a recent agreement by Amgen Inc. to buy ChemoCentryx Inc., could help turn Wall Street sentiment on biotech shares. The former highfliers have slumped in recent months due to market turmoil, scientific setbacks and fear of antitrust scrutiny of combinations.
Novavax drops 31% after massive 2Q topline miss
Biotech poised for H2 recovery as stocks rise amid quarterly results, M&A activity
- 08/06/2022
